Priyanka Matti - Oncology

 The Cancer Care Gap: Why Geography Still Determines Survival

My mother told me a story that has stuck with me forever: her aunt traveled over 200 miles on public transport, carrying her six year old son with leukemia, only to find the area’s pediatric oncology unit had run out of chemotherapy drugs. Stories like this surface regularly in medical journals, but they still hit hard every time.

Cancer kills differently depending on where you are born or reside. In wealthy countries, we’re pushing the boundaries with CAR-T therapy and personalized medicine. But across much of the developing world, patients still pass away from cancers that should be treatable with standard chemotherapy if it were available. The frank reality is that seven out of ten cancer deaths occur in low and middle income countries, where diagnosis often feels like a death sentence.

Yet I’ve been following some remarkable developments that give me hope. A study published last year described how telemedicine programs in rural Mexico connected local clinics with oncologists in major cities. Patients who previously had no access to specialist care were suddenly receiving expert guidance. It’s not a perfect solution, but survival rates have improved dramatically. 

Rwanda keeps appearing in the literature as a success story worth studying. They trained community health workers to spot early warning signs and built referral networks that actually function. Their childhood cancer program saw survival rates jump from 20% to over 60% in less than a decade. This wasn’t through expensive technology, but through smart outreach and organization. We know how to treat cancer. The real challenge is making that knowledge accessible everywhere.